Eli Lilly’s Zepbound proved more effective than Novo Nordisk’s Wegovy in a new head-to-head trial, though both medications ...

Novo Nordisk (NVO) stock in focus as the company promotes FDA-approved Wegovy as a ban for makers of compounding versions ...

About 71% of U.S. adults are either overweight or obese, according to the Centers for Disease Control. That makes it easy to ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

May 16 - As Denmark's Novo Nordisk shops for its next CEO to replace Lars Fruergaard Jorgensen, it should look across the Atlantic for a leader deeply entrenched in the United States, by far its ...

Around one-third of patients taking Wegovy saw improvement in both liver ... in 37 percent of people is important because that should translate to better outcomes and fewer people needing a ...

A s more doctors and patients turn to the latest weight-loss drugs, researchers are trying to figure out which drug is right ...

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...

Q. I took Wegovy for a few months last fall until I was unable to find a pharmacy that could fill my prescription. They were ...

With more and more people signing up for weight loss drugs, the potential side effects are starting to attract attention.

GLP-1 medications like Ozempic, Wegovy and Mounjaro have gone from obscure diabetes treatments to front-page news thanks to their powerful appetite-suppressing effects. But behind the hype – and the ...